Corpus Intelligence IC Memo — CHILDRENS HOSPITAL 2026-04-26 09:08 UTC
IC Memo — CHILDRENS HOSPITAL
Investment Committee Memorandum | DC | 323 beds | Grade B | EBITDA uplift $100.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CHILDRENS HOSPITAL

CCN 093300 | DC, DC | 323 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

CHILDRENS HOSPITAL is a 323-bed suburban community hospital in DC, DC with $1.36B in net patient revenue and a -8.2% operating margin. The hospital serves a payer mix of 0.1% Medicare, 12.4% Medicaid, and 87.5% commercial.

Thesis: Undervalued. Our ML models identify $100.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.2% to -0.9% (+736bps).

Net Revenue HCRIS$1.36B
Current EBITDA COMPUTED$-112.3M
Operating Margin COMPUTED-8.2%
Occupancy HCRIS89.3%
Revenue / Bed COMPUTED$4.2M
Net-to-Gross HCRIS38.4%
Distress Probability ML37.4%

2. Market Context & Competitive Position

12
DC Hospitals
-2.9%
State Median Margin
1421
Comparable Hospitals

DC has 12 Medicare-certified hospitals with a median operating margin of -2.9%. The target's margin of -8.2% places it below the state median. Among 1421 size-comparable peers (162-646 beds), the median margin is -3.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (162-646), prioritizing same-state peers. 1421 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CHILDRENS HOSPITAL (Target)DC323$1.36B-8.2%
ST. LUKES HOSPITALPA633$8.94B87.9%
MEMORIAL HOSPITAL FOR CANCER ANY514$4.34B-32.5%
U OF U HOSPITALS & CLINICSUT616$2.72B-1.8%
UNIVERSITY OF WI HOSPITALS & CWI644$2.68B3.2%
RONALD REAGAN UCLACA446$2.62B-6.8%
OHSU HOSPITAL AND CLINICSOR549$2.57B-6.3%
LUCILE PACKARD CHILDRENS HOSPICA394$2.39B-0.8%
UNIVERSITY OF MIAMI HOSP & CLIFL532$2.36B0.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $100.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$28.6M+210bp18mo
Cost to Collect4.5%2.5%$27.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$27.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$16.6M+122bp9mo
Clean Claim Rate88.0%96.0%$872K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$28.6M
Cost to Collect
$27.2M
Denial Rate Reduction
$27.0M
A/R Days Reduction
$16.6M
Clean Claim Rate
$872K
Total EBITDA Uplift$100.3M
Current EBITDA$-112.3M
+ RCM Uplift+$100.3M
Pro Forma EBITDA$-12.0M
Current Margin-8.2%
Pro Forma Margin-0.9%
WC Released (1x)$52.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-172.7M$262.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-172.7M$232.4M0.00x-100.0%
Bull Case9.0x11.0x$-155.5M$507.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-155.5M$507.4M0.00x-100.0%
Bear Case11.0x10.0x$-190.0M$-183.1M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-190.0M$-263.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 1421 hospitals with 162-646 beds
  • Same-state prioritization (n=6)
  • Comp margins: P25=-13.1% / P50=-3.6% / P75=5.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.